Edwards Lifesciences Corp (Edwards Lifesciences) is a medical technology company that is engaged in the development, manufacturing and marketing of devices for structural heart disease, critical care and surgical monitoring. The company’s products include surgical valve repair devices, surgical valve replacement, hemodynamic monitoring devices, transcatheter heart valves, pressure monitoring devices, and related instruments and accessories. Its products find application in various therapies, including transcatheter aortic valve replacement (TAVR), blood conservation, infection control, enhanced surgical recovery, and for the management of clotting, hypotension and sepsis. The company markets products through direct sales force and also a network of independent distributors in North America, Europe and Asia-Pacific, among others. Edwards Lifesciences is headquartered in Irvine, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Edwards Lifesciences Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Edwards Lifesciences Corp Company Overview
- Edwards Lifesciences Corp Company Snapshot
- Edwards Lifesciences Corp Pipeline Products and Ongoing Clinical Trials Overview
- Edwards Lifesciences Corp - Pipeline Analysis Overview
- Business Description
- Edwards Lifesciences Corp - Key Facts
- Edwards Lifesciences Corp - Major Products and Services
- Edwards Lifesciences Corp Pipeline Products by Development Stage
- Edwards Lifesciences Corp Ongoing Clinical Trials by Trial Status
- Edwards Lifesciences Corp Pipeline Products Overview
- Acumen HPI Software
- Acumen HPI Software Product Overview
- APTURE
- APTURE Product Overview
- CardiAQ Mitral Valve
- CardiAQ Mitral Valve Product Overview
- CardiAQ Mitral Valve Clinical Trial
- Cardinal Adjustable Annuloplasty Ring System - Tricuspid Repair
- Cardinal Adjustable Annuloplasty Ring System - Tricuspid Repair Product Overview
- Cardioband Direct Access
- Cardioband Direct Access Product Overview
- Cardioband System - Tricuspid Regurgitation
- Cardioband System - Tricuspid Regurgitation Product Overview
- Cardioband System - Tricuspid Regurgitation Clinical Trial
- Carpentier-Edwards BioPhysio Aortic Valve
- Carpentier-Edwards BioPhysio Aortic Valve Product Overview
- Coapsys
- Coapsys Product Overview
- Edwards Cardioband Mitral Reconstruction System
- Edwards Cardioband Mitral Reconstruction System Product Overview
- Edwards Cardioband Mitral Reconstruction System Clinical Trial
- Edwards EWJ-202 Transcatheter Tricuspid Valve Replacement System
- Edwards EWJ-202 Transcatheter Tricuspid Valve Replacement System Product Overview
- Edwards EWJ-202 Transcatheter Tricuspid Valve Replacement System Clinical Trial
- Edwards Intuity Elite Sizer
- Edwards Intuity Elite Sizer Product Overview
- EOS
- EOS Product Overview
- Esheath+
- Esheath+ Product Overview
- ESSANA
- ESSANA Product Overview
- EVOQUE Mitral Eos Valve Replacement Device
- EVOQUE Mitral Eos Valve Replacement Device Product Overview
- EVOQUE Mitral Eos Valve Replacement Device Clinical Trial
- EVOQUE Tricuspid Valve Replacement System
- EVOQUE Tricuspid Valve Replacement System Product Overview
- EVOQUE Tricuspid Valve Replacement System Clinical Trial
- FORETELL
- FORETELL Product Overview
- FORMA Tricuspid Repair System
- FORMA Tricuspid Repair System Product Overview
- FORMA Tricuspid Repair System Clinical Trial
- FORTIS Mitral Transcatheter Heart Valve
- FORTIS Mitral Transcatheter Heart Valve Product Overview
- FORTIS Mitral Transcatheter Heart Valve Clinical Trial
- GLX Aortic Conduit
- GLX Aortic Conduit Product Overview
- HARPOON Beating Heart Mitral Valve Repair System
- HARPOON Beating Heart Mitral Valve Repair System Product Overview
- HARPOON Beating Heart Mitral Valve Repair System Clinical Trial
- HemoSphere Connectivity Suite
- HemoSphere Connectivity Suite Product Overview
- Integrated Semi-Closed Loop System
- Integrated Semi-Closed Loop System Product Overview
- Magna Ease Surgical Valve With GLX
- Magna Ease Surgical Valve With GLX Product Overview
- MOBIUS Leaflet Repair System
- MOBIUS Leaflet Repair System Product Overview
- Monarc Transcatheter Mitral Repair System
- Monarc Transcatheter Mitral Repair System Product Overview
- MultiShot
- MultiShot Product Overview
- Next Gen CENTERA
- Next Gen CENTERA Product Overview
- Next Generation Mitral Heart Valve
- Next Generation Mitral Heart Valve Product Overview
- Next-Gen EndoVent With Pacing
- Next-Gen EndoVent With Pacing Product Overview
- Next-Gen QuickDraw Cannula
- Next-Gen QuickDraw Cannula Product Overview
- OEM Module Combination Device
- OEM Module Combination Device Product Overview
- PASCAL Ace Transcatheter Tricuspid Valve Repair System
- PASCAL Ace Transcatheter Tricuspid Valve Repair System Product Overview
- PASCAL Precision Transcatheter Tricuspid Valve Repair System
- PASCAL Precision Transcatheter Tricuspid Valve Repair System Product Overview
- PASCAL Precision Transcatheter Valve Repair System
- PASCAL Precision Transcatheter Valve Repair System Product Overview
- PASCAL STABILX
- PASCAL STABILX Product Overview
- PASCAL Transcatheter Mitral Valve Repair System - FMR
- PASCAL Transcatheter Mitral Valve Repair System - FMR Product Overview
- PASCAL Transcatheter Mitral Valve Repair System - FMR Clinical Trial
- PASCAL Transcatheter Tricuspid Valve Repair System
- PASCAL Transcatheter Tricuspid Valve Repair System Product Overview
- PASCAL Transcatheter Tricuspid Valve Repair System Clinical Trial
- SAPIEN 3 THV - Asymptomatic Severe Aortic Stenosis
- SAPIEN 3 THV - Asymptomatic Severe Aortic Stenosis Product Overview
- SAPIEN 3 THV - Asymptomatic Severe Aortic Stenosis Clinical Trial
- SAPIEN 3 THV - Moderate Aortic Stenosis
- SAPIEN 3 THV - Moderate Aortic Stenosis Product Overview
- SAPIEN 3 THV - Moderate Aortic Stenosis Clinical Trial
- Sapien 3 Ultra Evolutionary Transcatheter Heart Valve
- Sapien 3 Ultra Evolutionary Transcatheter Heart Valve Product Overview
- SAPIEN M3
- SAPIEN M3 Product Overview
- SAPIEN M3 Clinical Trial
- SAPIEN X4
- SAPIEN X4 Product Overview
- Sutrafix
- Sutrafix Product Overview
- Trialign Percutaneous Tricuspid Valve Annuloplasty System
- Trialign Percutaneous Tricuspid Valve Annuloplasty System Product Overview
- Trialign Percutaneous Tricuspid Valve Annuloplasty System Clinical Trial
- V-Chordal System - Transfemoral
- V-Chordal System - Transfemoral Product Overview
- V-Chordal-Off Pump
- V-Chordal-Off Pump Product Overview
- Edwards Lifesciences Corp - Key Competitors
- Edwards Lifesciences Corp - Key Employees
- Edwards Lifesciences Corp - Key Employee Biographies
- Edwards Lifesciences Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Edwards Lifesciences Corp, Recent Developments
- May 17, 2023: Data from benchmark registry demonstrate improved TAVR efficiency with preserved patient safety
- Mar 06, 2023: Edwards highlights new data at ACC related to lifetime management of aortic stenosis
- Dec 08, 2022: Edwards Lifesciences Announces CEO Succession Plan
- Oct 20, 2022: Edwards Lifesciences to Host Earnings Conference Call on October 27, 2022
- Sep 12, 2022: Edwards launches Sapien 3 Ultra Resilia Valve following FDA approval
- Jul 21, 2022: Edwards Lifesciences to Host Earnings Conference Call on July 28, 2022
- May 23, 2022: Edwards Lifesciences to Present at the Bernstein 38th Annual Strategic Decisions Conference
- Apr 19, 2022: Edwards Lifesciences to Host Earnings Conference Call on April 26, 2022
- Mar 31, 2022: Edwards Mitris Resilia valve receives FDA approval for mitral replacement surgeries
- Jan 19, 2022: Edwards Lifesciences to Host Earnings Conference Call on January 26, 2022
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Edwards Lifesciences Corp Pipeline Products and Ongoing Clinical Trials Overview
- Edwards Lifesciences Corp Pipeline Products by Equipment Type
- Edwards Lifesciences Corp Pipeline Products by Indication
- Edwards Lifesciences Corp Ongoing Clinical Trials by Trial Status
- Edwards Lifesciences Corp, Key Facts
- Edwards Lifesciences Corp, Major Products and Services
- Edwards Lifesciences Corp Number of Pipeline Products by Development Stage
- Edwards Lifesciences Corp Pipeline Products Summary by Development Stage
- Edwards Lifesciences Corp Ongoing Clinical Trials by Trial Status
- Edwards Lifesciences Corp Ongoing Clinical Trials Summary
- Acumen HPI Software - Product Status
- Acumen HPI Software - Product Description
- APTURE - Product Status
- APTURE - Product Description
- CardiAQ Mitral Valve - Product Status
- CardiAQ Mitral Valve - Product Description
- CardiAQ Mitral Valve - Early Feasibility Study of the Edwards EVOQUE Transcatheter Mitral Valve Replacement System For the Treatment of Moderate to Severe Mitral Regurgitation
- Cardinal Adjustable Annuloplasty Ring System - Tricuspid Repair - Product Status
- Cardinal Adjustable Annuloplasty Ring System - Tricuspid Repair - Product Description
- Cardioband Direct Access - Product Status
- Cardioband Direct Access - Product Description
- Cardioband System - Tricuspid Regurgitation - Product Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Boston Scientific Corp
- Lidco Group Ltd
- LivaNova Plc
- Medtronic Plc
- Pulsion Medical Systems SE
